Amoxicillin-Clavulanate (Augmentin)
The generic name of the recommended next antibiotic for an adult with acute bacterial sinusitis who has not improved after 10 days of amoxicillin is amoxicillin-clavulanate.
Rationale for Switching to Amoxicillin-Clavulanate
When amoxicillin fails after 10 days, the primary concern is bacterial resistance—specifically beta-lactamase-producing organisms (Haemophilus influenzae, Moraxella catarrhalis) and penicillin-resistant Streptococcus pneumoniae. The clavulanate component inhibits beta-lactamase enzymes, restoring amoxicillin's effectiveness against these resistant pathogens 1.
High-dose amoxicillin-clavulanate (2 g amoxicillin/125 mg clavulanate twice daily for adults, or 90 mg/kg/day amoxicillin component for children) is specifically recommended for treatment failures 1, 2. This dosing overcomes penicillin-resistant S. pneumoniae while maintaining coverage of beta-lactamase producers.
Alternative Options for Penicillin Allergy
If the patient has a documented penicillin allergy:
- Respiratory fluoroquinolones (levofloxacin or moxifloxacin) are first-line alternatives 2
- Doxycycline is another acceptable option 2
- Second/third-generation cephalosporins (cefuroxime, cefpodoxime, cefdinir) for non-type I hypersensitivity reactions 1
Avoid macrolides (azithromycin, clarithromycin) and trimethoprim-sulfamethoxazole due to high resistance rates: >40% for S. pneumoniae with macrolides and 50% with TMP-SMX 2.
Duration and Monitoring
Continue treatment for 10-14 days total, or until symptom-free plus 7 additional days 1. If no improvement occurs within 3-5 days of switching antibiotics, consider:
- CT imaging to evaluate for complications
- Consultation with otolaryngology or allergy/immunology
- Evaluation for underlying conditions (immunodeficiency, anatomic abnormalities, chronic rhinosinusitis) 1
Common Pitfalls
The most recent high-quality evidence from 2026 suggests that standard-dose amoxicillin may be equally effective as amoxicillin-clavulanate for uncomplicated acute sinusitis in adults 18-64 years, with lower rates of adverse events including diarrhea and secondary infections 3. However, this applies to initial treatment, not treatment failures. When amoxicillin has already failed, the guidelines consistently recommend escalation to amoxicillin-clavulanate to cover resistant organisms 1, 2.
Watch for severe diarrhea and Clostridioides difficile infection, which occur more frequently with amoxicillin-clavulanate than amoxicillin alone 3. Patients should be counseled to report any diarrhea or bloody stools immediately 1.